All‐cause mortality · high‐risk surgical patients with acute calculous cholecystitis.
It is very uncertain whether intervention changes mortality compared with control (very low certainty).
1 finding from 1 review
Perinatal mortality · pregnant women
One intervention showed no clear difference in perinatal mortality compared with no intervention (moderate certainty).
1 finding from 1 review
All‐cause mortality · COPD and at least one other long‐term condition
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality (deaths) Â · COPD and at least one other long‐term condition
It is very uncertain whether intervention changes all‐cause mortality (deaths) Â compared with usual care (very low certainty).
1 finding from 1 review
ICU mortality · people admitted to intensive care units
Interventions showed no clear difference in all‐cause mortality in ICU compared with placebo or no prophylaxis (low certainty).
1 finding from 1 review
All‐cause mortality · Adults undergoing pelvic radiotherapy
1 finding from 1 review
no estimate extracted
905 participants
Very low
All‐cause mortality · people living beyond cancer
Dietary intervention showed no clear difference in mortality compared with control (low certainty).
1 finding from 1 review
Tuberculosis mortality · Individuals of all ages
1 finding from 1 review
All‐cause mortality · s
It is very uncertain whether EHealth interventions changes mortality compared with standard care (very low certainty).
1 finding from 1 review
All‐cause mortality · people undergoing laparoscopic cholecystectomy.
1 finding from 1 review
60‐day mortality ‐ Aprotinin versus control · Patients with liver transplantation.
It is very uncertain whether intervention changes 60‐day mortality ‐ Aprotinin versus control compared with control (very low certainty).
1 finding from 1 review
Mortality ‐ Antibiotics versus no antibiotics · patients undergoing liver resections
1 finding from 1 review
Mortality ‐ Prebiotics and probiotics versus none · patients undergoing liver resections
1 finding from 1 review
60‐day mortality ‐ Tranexamic acid versus control · Patients with liver transplantation.
It is very uncertain whether intervention changes 60‐day mortality ‐ Tranexamic acid versus control compared with control (very low certainty).
1 finding from 1 review
60‐day mortality ‐ Tranexamic acid versus aprotinin · Patients with liver transplantation.
It is very uncertain whether intervention changes 60‐day mortality ‐ Tranexamic acid versus aprotinin compared with control (very low certainty).
1 finding from 1 review
All‐cause mortality · children with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · children with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
60‐day mortality ‐ Recombinant factor VIIa (rFVIIa) versus control · Patients with liver transplantation.
It is very uncertain whether intervention changes 60‐day mortality ‐ Recombinant factor VIIa (rFVIIa) versus control compared with control (very low certainty).
1 finding from 1 review
Mortality ‐ Long duration antibiotics versus short duration antibiotics · patients undergoing liver resections
1 finding from 1 review
Mortality ‐ Topical povidone iodine gel versus no topical povidone iodine gel · patients undergoing liver resections
It is very uncertain whether intervention changes mortality ‐ Topical povidone iodine gel versus no topical povidone… compared with comparison (very low certainty).
1 finding from 1 review